Pretreatment FDG PET can provide useful information on the expression of immune checkpoints and the metabolic state of the tumor microenvironment (34), and 18F-FDG uptake is correlated with the expression of PD-1/PD-L1 in lung cancer and bladder cancer (35–37). This evidence concerns the gene CD274 and urinary bladder carcinoma.